Use of Leukotriene-Receptor Antagonists During Pregnancy and Risk of Neuropsychiatric Events in Offspring

JAMA Netw Open. 2023 Mar 1;6(3):e231934. doi: 10.1001/jamanetworkopen.2023.1934.
No abstract available

Plain language summary

This cohort study examines the association of the use of leukotriene-receptor antagonists during pregnancy with the risk of neuropsychiatric events in offspring.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Humans
  • Leukotriene Antagonists* / therapeutic use
  • Leukotrienes*
  • Pregnancy


  • Leukotriene Antagonists
  • Leukotrienes